CSI Market
Sign In | Register

4d Molecular Therapeutics Inc (FDMT) Annual Balance Sheets

Annual · GAAP · USD millions
Access FDMT quarterly Balance Sheets →
The table below presents a historical view of 4d Molecular Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent60.24
Marketable Securities, Current SH342.41
Cash & Short-term Investments402.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current10.48
Total Current Assets413.13
Equipment/Property/Plant Net14.87
Long-term investments111.38
Other Assets, Noncurrent138.71
Operating Lease Right Of Use Asset18.14
Total Assets566.71
Liabilities
Accounts Payable, Current AC11.16
Accrued Liabilities, Current AC26.87
Other Liabilities, Current5.95
Total Current Liabilities43.99
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.36
Other liabilities, Noncurrent16.70
Contract With Customer Liability Current0.36
Contract With Customer Liability Noncurrent0.75
Operating Lease Liability Noncurrent15.82
Total Liabilities61.05
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,221.24
Retained Earnings / Accumulated Deficit-716.30
Other Equity0.73
Common Stockholder's Equity505.66
Total Stockholder's Equity505.66
Liabilities & Stockholder's Equity566.71
4 historic quarters locked

Sign in to unlock the full 4d Molecular Therapeutics Inc balance sheet history.

Sign In Create Free Account

About 4D Molecular Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-114075

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License